Literature DB >> 7682603

Long-term treatment with glucocorticoids increases synthesis and stability of junctional acetylcholine receptors on innervated cultured human muscle.

S Braun1, V Askanas, W K Engel, E N Ibrahim.   

Abstract

We have studied the effect of long-term treatment with hydrocortisone on the expression of acetylcholine receptors (AChRs) at the neuromuscular junctions of human muscle cultured in monolayer and innervated de novo by fetal rat spinal cord motoneurons. Hydrocortisone increased accumulation of junctional AChRs in a dose- and time-dependent fashion. This increase was due to both decreased degradation and increased synthesis of AChRs. Other glucocorticoids, dexamethasone and prednisolone, exerted similar effects. Our study demonstrates a novel action of glucocorticoids on human junctional AChRs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682603     DOI: 10.1111/j.1471-4159.1993.tb13422.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  A subchronic application period of glucocorticoids leads to rat cognitive dysfunction whereas physostigmine induces a mild neuroprotection.

Authors:  Katrin Wüppen; Dirk Oesterle; Sabina Lewicka; Jürgen Kopitz; Konstanze Plaschke
Journal:  J Neural Transm (Vienna)       Date:  2010-07-27       Impact factor: 3.575

2.  The impact of cortisol in steatotic and non-steatotic liver surgery.

Authors:  María Eugenia Cornide-Petronio; Esther Bujaldon; Mariana Mendes-Braz; Cindy G Avalos de León; Mónica B Jiménez-Castro; Ana I Álvarez-Mercado; Jordi Gracia-Sancho; Juan Rodés; Carmen Peralta
Journal:  J Cell Mol Med       Date:  2017-04-04       Impact factor: 5.310

3.  Effect of protracted dexamethasone exposure and its withdrawal on rocuronium-induced neuromuscular blockade and sugammadex reversal: an ex vivo rat study.

Authors:  Seok Kyeong Oh; Byung Gun Lim; Sungsoo Park; Hong Seuk Yang; Junyong In; Yong Beom Kim; Hey-Ran Choi; Il Ok Lee
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.